Profiel
Lixian Jiang is currently the Chief Operating Officer & Vice President at Cz Biomed Corp.
Prior to this, he worked as the Chief Operating Officer at Stem Cell Therapy International, Inc. and as the Chief Operating Officer-China Division at AmStem Corp.
He holds a doctorate degree from the University of South Florida.
Actieve functies van Lixian Jiang
| Bedrijven | Functie | Begin |
|---|---|---|
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Operationeel Directeur | - |
Eerdere bekende functies van Lixian Jiang
| Bedrijven | Functie | Einde |
|---|---|---|
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Operationeel Directeur | 09-02-2010 |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Corporate Officer/Principal | 09-02-2010 |
Opleiding van Lixian Jiang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Commercial Services |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Health Technology |
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















